Tag Archives: BVX

Hot High Tech Stocks For 2019

Motilal Oswal has come out with its second quarter (July-September’ 18) earnings estimates for the Automobiles sector. The brokerage house expects Ashok Leyland to report net profit at Rs. 521.2 crore up 55.9% year-on-year (up 37% quarter-on-quarter).

Net Sales are expected to increase by 26.8 percent Y-o-Y (up 22.7 percent Q-o-Q) to Rs. 7,670.1 crore, according to Motilal Oswal.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 39.6 percent Y-o-Y (up 31.9 percent Q-o-Q) to Rs. 854.1 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More

Hot High Tech Stocks For 2019: Kronos Worldwide Inc(KRO)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Kronos Worldwide (NYSE:KRO) plunged on Wednesday after the company announced first-quarter 2018 results. The titanium dioxide manufacturer reported strong growth compared to the year-ago period thanks to the continued surge in selling prices. Revenue was up 16% and net income nearly doubled relative to the first quarter of 2017. How can Wall Street be displeased with that? 

  • [By Maxx Chatsko]

    Despite continued strength globally for the material, many titanium dioxide producers have seen their share prices drop by double digits since the beginning of the year. For instance, Kronos Worldwide (NYSE:KRO) stock has dropped by 19% in 2018 even though the business is cruising along right now. That has pushed its dividend yield to 3.4% — much higher than most peers.

  • [By Timothy Green, Travis Hoium, and Maxx Chatsko]

    No matter your investing style, stocks that no one is paying attention to are often the best deals. Unpopular or lightly followed dividend stocks can become depressed in price, pushing up the yields and creating bargains for eagle-eyed investors. Three of our Motley Fool contributors think Vodafone (NASDAQ:VOD), Hanesbrands (NYSE:HBI), and Kronos Worldwide (NYSE:KRO) aren’t getting the attention they deserve. Here’s why these dividend stocks would make a great addition to your portfolio.

  • [By Max Byerly]

    Shares of Kronos Worldwide, Inc. (NYSE:KRO) have been given a consensus recommendation of “Hold” by the six research firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $25.33.

  • [By Shane Hupp]

    Kronos Worldwide (NYSE:KRO) issued its earnings results on Monday. The specialty chemicals company reported $0.21 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.22 by ($0.01), Fidelity Earnings reports. Kronos Worldwide had a return on equity of 33.77% and a net margin of 12.94%. The company had revenue of $349.40 million for the quarter, compared to the consensus estimate of $378.00 million.

Hot High Tech Stocks For 2019: Kyocera Corporation(KYO)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Japanese materials giant Kyocera (NYSE:KYO) gained 12.1% in April 2018, according to data from S&P Global Market Intelligence. The stock rode a strong fourth-quarter report to these gains despite zero coverage in the financial press.

  • [By Max Byerly]

    Media coverage about Kyocera (NYSE:KYO) has trended somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kyocera earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 44.4825472854626 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Shane Hupp]

    Taiwan Semiconductor Mfg. (NYSE:TSM) and Kyocera (NYSE:KYO) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

  • [By Logan Wallace]

    Media stories about Kyocera (NYSE:KYO) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kyocera earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 44.7168933477613 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Hot High Tech Stocks For 2019: Great Southern Bancorp, Inc.(GSBC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    GSA Capital Partners LLP bought a new position in Great Southern Bancorp, Inc. (NASDAQ:GSBC) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 17,738 shares of the financial services provider’s stock, valued at approximately $1,015,000.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Great Southern Bancorp (GSBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Great Southern Bancorp, Inc. (NASDAQ:GSBC) VP Linton J. Thomason sold 3,900 shares of the stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $60.15, for a total value of $234,585.00. Following the transaction, the vice president now directly owns 7,278 shares in the company, valued at approximately $437,771.70. The transaction was disclosed in a filing with the SEC, which is available at this link.

Hot High Tech Stocks For 2019: Panhandle Royalty Company(PHX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Panhandle Oil and Gas (NYSE:PHX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Tuesday.

  • [By Logan Wallace]

    Media headlines about Panhandle Oil and Gas (NYSE:PHX) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Panhandle Oil and Gas earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave news stories about the oil and gas producer an impact score of 50.7768748674153 out of 100, indicating that recent news coverage is somewhat likely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    News headlines about Panhandle Oil and Gas (NYSE:PHX) have trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Panhandle Oil and Gas earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned media stories about the oil and gas producer an impact score of 46.1120655512436 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “Panhandle Oil and Gas Inc. (PHX) VP Purchases $49,760.00 in Stock” was reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at www.tickerreport.com/banking-finance/4147013/panhandle-oil-and-gas-inc-phx-vp-purchases-49760-00-in-stock.html.

Hot High Tech Stocks For 2019: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

Top Gold Stocks To Buy Right Now

A rather unusual thing has just happened with Cliffs Natural Resources (NYSE:CLF). The company issued a press release which stated that Barron’s and Axiom Capital Management issued materially misleading statements regarding Cliffs’ CEO share purchases. Cliffs stated that it believed that the materially misleading statements were an intentional attempt to manipulate Cliffs’ share price to support the bearish position of Axiom and that the company had instructed its outside legal counsel to pursue appropriate legal action against all parties involved.

I am not a lawyer and I cannot comment on the legal side of this story. However, I have a strong view regarding another comment that Axiom’s Gordon Johnson, who is notoriously bearish on steel and iron ore, has made regarding Cliffs’ stock. According to Mr. Johnson, the recent purchase of 200,000 Cliffs shares by Cliffs’ CEO Lourenco Goncalves is bearish because Goncalves’ track record in purchasing Cliffs’ shares is poor.

I find it very strange that an analyst decides to share his view on a CEO market timing ability. Mr. Johnson’s logic is the same as, for example, when one says: “Goldman Sachs has just issued a buy rating on XYZ, so XYZ is a sell”. This is suitable for a private conversation but cannot be used for public discourse by an analyst of an investment firm. Purchases by members of the management team are not necessarily a bullish factor for the stock, however, I cannot find a single reason why management’s purchase of stock could be fundamentally bearish.

Top Gold Stocks To Buy Right Now: Comcast Corporation(CCV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CounterPath Co. (NASDAQ:CPAH) (TSE:CCV) has been given a consensus broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports.

Top Gold Stocks To Buy Right Now: Boston Private Financial Holdings, Inc.(BPFH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Boston Private Financial Hldg Inc (NASDAQ:BPFH) – Equities research analysts at SunTrust Banks cut their Q2 2018 earnings estimates for Boston Private Financial in a report released on Sunday, May 20th. SunTrust Banks analyst M. Young now expects that the bank will post earnings per share of $0.10 for the quarter, down from their previous forecast of $0.20.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Boston Private Financial (BPFH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Gold Stocks To Buy Right Now: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Gold Stocks To Buy Right Now: Innophos Holdings, Inc.(IPHS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    TheStreet upgraded shares of Innophos (NASDAQ:IPHS) from a c+ rating to a b rating in a research note published on Wednesday.

    Several other analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Innophos from a hold rating to a sell rating in a report on Tuesday, February 27th. BidaskClub downgraded shares of Innophos from a sell rating to a strong sell rating in a report on Tuesday, February 27th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innophos (IPHS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Top Gold Stocks To Buy Right Now: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

Top Gold Stocks To Buy Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Stephan Byrd]

    State Board of Administration of Florida Retirement System trimmed its stake in shares of Nucor (NYSE:NUE) by 5.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 441,516 shares of the basic materials company’s stock after selling 23,506 shares during the period. State Board of Administration of Florida Retirement System owned about 0.14% of Nucor worth $26,972,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nucor (NUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Energy Stocks To Watch For 2018

Goldman Sachs thinks it’s time to pull the plug on Tesla’s stock.

David Tamberrino, an analyst at the influential Wall Street investment bank, downgraded Tesla’s stock to a “sell” rating on Monday morning. It’s pretty rare for analysts to be that negative about a high-profile company.

Tesla’s stock fell nearly 5% Monday and shares are now down more than 10% since the company reported its latest financial results last week. Tamberrino lowered his price target only slightly, from $190 to $185.

But a price of $185 is more than 25% below the $257 level it closed at on Friday. Shares were trading around $246 Monday following the downgrade.

Although Tesla (TSLA) recently said there’s strong demand for its Model S and Model X electric cars as well as the upcoming Model 3 — Tesla’s more affordable vehicle that should be available later this year — investors are nervous about all that Tesla has on its plate.

Tesla also recently bought SolarCity, an alternative energy company that is run by two cousins of Tesla CEO Elon Musk.

Top Energy Stocks To Watch For 2018: Allot Communications Ltd.(ALLT)

Advisors’ Opinion:

  • [By Max Byerly]

    Allot Communications (NASDAQ:ALLT) will be posting its quarterly earnings results before the market opens on Tuesday, May 8th. Analysts expect Allot Communications to post earnings of ($0.10) per share for the quarter.

  • [By Joseph Griffin]

    IBM (NYSE: IBM) and Allot Communications (NASDAQ:ALLT) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation.

Top Energy Stocks To Watch For 2018: TFS Financial Corporation(TFSL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TFS Financial (TFSL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Energy Stocks To Watch For 2018: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd